Xtant Medical Holdings (XTNT) Misses Q1 EPS by 1c ; Offers Guidance

Xtant Medical Holdings (NYSE: XTNT) reported Q1 EPS of ($0.02), $0.01 worse than the analyst estimate of ($0.01). Revenue for the quarter came in at $20.9 million versus the consensus estimate of $22 million.

GUIDANCE:

Xtant Medical Holdings sees FY2026 revenue of $101-105 million, versus the consensus of $97.34 million.

For earnings history and earnings-related data on Xtant Medical Holdings (XTNT) click here.

You May Also Be Interested In

• Is Treasury selloff a major issue for stock market bulls?
• SpaceX (SPCX) call put ratio 1.7 calls to 1 put as share price up 5%
• SpaceX (SPCX) gains nearly 6% as traders follow the money